Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant

Details for Australian Patent Application No. 2006254675 (hide)

International Classifications

Event Publications

3 January 2008 PCT application entered the National Phase

PCT publication WO2006/128288 Priority application(s): WO2006/128288

24 April 2008 Alteration of Name

The name of the applicant has been altered to Thallion Pharmaceuticals Inc.

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.